trending Market Intelligence /marketintelligence/en/news-insights/trending/2rSaz72XdshKHYAZjlnvOQ2 content esgSubNav
In This List

Lupin CFO to resign

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise

Blog

Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises


Lupin CFO to resign

Lupin Ltd. said Ramesh Swaminathan would step down as the company's CFO in December.

The company said Swaminathan has decided to resign to pursue other responsibilities outside the pharmaceutical industry.

Mumbai, India-based Lupin is a pharmaceutical company that develops, produces, and markets a range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients worldwide.